This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
Having reported over 70% increase in revenues over the past 5-6 years, the market for biologically derived products is currently estimated to be worth more than USD 200 billion. Our Social Media Platform Web: [link] LinkedIn: [link] Twitter: [link] The post Subcutaneous Medications and DrugDeliverySystems appeared first on Blog.
Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drugdelivery have been highlighted in the figure.
Global Inhaled and Intranasal Products 2020-2030: Contract Service Providers Market – Focus on Drugs and DrugDeliverySystems – ResearchAndMarkets.com Global Inhaled and Intranasal Products 2020-2030: Contract Service Providers Market – Focus on Drugs and DrugDeliverySystems – ResearchAndMarkets.com … Continue reading (..)
SHL Medical is a world-leading solutions provider for advanced drugdeliverysystems with a unified purpose to further enable patient independence. The company’s most prominent products are its autoinjectors, which are seeing growing global demand. It will be high-tech, fully automated production,” Turvill adds. “A
IN-ARMOR will use computer-aided drug design and in silico approaches, as well as a nanotech-based drugdeliverysystem. An existing drug platform will also be optimised by the project for its first target indication. Once completed, the project will be advanced to clinical validation.
Elyxyb is a prescription nonsteroidal anti-inflammatory drug (NSAID) used for acute migraine treatment in adult patients with or without aura. It is formulated using a self-micro-emulsifying drugdeliverysystem that improves the drug’s bioavailability and solubility.
Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drugdelivery strategies to the long-acting drugdelivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.
The FDA has issued a warning about dosing errors and subsequent adverse events related to compounded semaglutide injectable products. These issues primarily stem from patients and healthcare providers miscalculating or incorrectly administering the drug. These errors have led to some patients being hospitalized due to overdoses.
We have put in our best effort to make it easily graspable what are the intracellular drugdelivery technologies and how it can ensure effective treatment for fatal disease. Below are the highlights that we feel would be helpful to understand about the intracellular drugdelivery / intracellular non-viral drugdelivery approach.
Antares Pharma overview Antares Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. It also develops products to reduce the risk of preterm birth in pregnant women.
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This could equate to significant savings when considering the large-scale production and distribution of major vaccines. Lower materials usage and easier storage and disposal are further advantages.
The production of commercial dose non-sterile products such as tablets, capsules, ointments, creams, and powders is rising due to their growing global demand, attributed to increasing demand for anti-ageing products, hereditary factors, genetic mutations, exposure to harmful radiation, and rising geriatric population.
CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drugdeliverysystems for newly developed biologics along with medical and diagnostic products.
Indaptus Therapeutics overview Indaptus Therapeutics (Intec Pharma) is a biopharmaceutical company developing drugs based on its proprietary Accordion Pill technology.
However, several drugdelivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous drugdeliverysystems – the helping hand for patients. Examples of some of the most popular types of drugdeliverysystems have been depicted below.
SLNs offer various benefits, such as easy production process, good release profile and low cost. However, their drawbacks include limited drug loading capacity and potential drug expulsion during storage. In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion.
It indicates that nanomedicine also has the potential to combat the threat of antibiotic resistance via the use of nanomaterials with intrinsic antibacterial properties, as well as using nanoparticles as effective drugdeliverysystems for antibacterial agents.
In a class of medical products called bronchodilators, Par’s albuterol sulfate provides fast breathing relief for people with asthma and COPD (chronic obstructive pulmonary disease). More specifically, different aspects of its production occur in three countries. Where’s it made? Three countries have a hand in making it.
As we explained back in March , Teva had initiated Hatch-Waxman pre-launch patent litigation against Amneal for infringement of 5 Orange Book-listed patents reading on the device constituent (a metered dose inhaler) of Teva’s combination product ProAir HFA. b)(1) that drugproduct patents may be listed if they claim the “drugproduct.
As always, we hope your day is productive and meaningful. The companies allege Moderna’s vaccine uses their technology for a drug-deliverysystem without permission. Citing Our choice today is the ever-seasonal pumpkin spice, for those tracking this sort of thing. And please do keep in touch.
The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The patch itself is made of biodegradable nanocellulose and contains no plastic additives. Behfar, senior scientist at VTT, in the news release.
One of the key objectives behind the aforementioned developments is to overcome issues related to high costs associated with the design and production of such pharmacological interventions. Over 40 oral drugdelivery technologies have been designed so far. Oral Protein / Peptide-based Drugs. Our Social Media Platform.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. Director, Head of Global Regulatory Affairs – Devices and Combination Products, Takeda. Who should Attend: Drug-delivery developers.
Register for this free webinar to learn the best practices to successfully incorporate 2022 ISO 11608 methodology to mitigate risk and accelerate time to market in combination product development. Plausible Alternative Medical Device Sterilization Methods and Reducing EtO Emissions.
The onset of the COVID-19 pandemic has contributed greatly to the increasing demand of oligonucleotide-based products, consequently, proposing lucrative opportunities for custom / contract service providers engaged in this domain. It is worth highlighting that oligonucleotide synthesis is a complex and labor-intensive process. Web: [link].
The production of such drugproducts requires skilled labor, stringent manufacturing protocols and specialized expertise. Additionally, they also require appropriate drugdeliverysystems to efficiently administer the intervention (in a manner that they can avoid degradation by cellular endonucleases).
The company developing drugproduct through such an intense process, use to consider container closure system only for packaging of the product. [1] 1] However, gradually it was realized that container closure integrity is a key factor that maintains product stability and sterility throughout its shelf life.
According to an analysis of the 2013 Medical Expenditure Panel Survey, one in six US adults reported taking a psychiatric drug at least once in 2013. Global sales of over-the-counter and prescription products related to central nervous system (CNS) disease added up to $86 billion in 2019. Intrathecal Chemotherapy.
The FTC expressed concern that patent listings that do not meet the statutory criteria undermine the competitive process, may disincentivize investment in developing generic and follow-on products, and reduce patient access to more affordable drugs thereby increasing costs to the healthcare system.
In the dynamic landscape of the healthcare sector, the evolution of drugdeliverysystems plays a significant role in transforming the management of chronic diseases. These devices reduce injection anxiety, and are useful for patients who prefer a hands-free drugdelivery experience.
You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and DrugDeliverySystems Market. Myeloid Cells Targeting Therapeutics Market. Our Social Media Platform. Web: [link]. Medium: [link].
Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility. Nanoparticles Contract Manufacturing. Web: [link].
Advances in drug discovery and development technologies / platforms have increased the likelihood of targeting a number of the aforementioned types of biological targets. As a result, novel product development opportunities have emerged and are likely to benefit both drug developers and investors alike.
The strategy involves creating an entirely new demand for products or services, transcending the constraints of existing demand. New DrugDelivery Methods New drugdelivery methods can help improve patient outcomes and reduce side effects, In addition, these methods can also increase patient adherence to medication regimens.
Healthcare accounts for more than 10% of Gross Domestic Product (GDP) of many developed countries. AI is able to mine records, design treatment studies, find out targets of drugdelivery in a way more drastic manner than a human can. The US’s most substantial employer is – Healthcare Sector. Nanotechnology.
Driven by the increasing need for safe and efficient medical devices and drugdeliverysystems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. There has been a rise in the development of polymers for biopharma with improved biocompatibility, biodegradability and functionality.
In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. In the last decade, biopharmaceutical excipient development has advanced significantly, resulting in more complex excipients that can be formulated as novel drugdelivery formulations. Our Social Media Platform.
Events related to Liposome Development and Manufacturing, organized Globally In the past few years, various types of events (webinars / conferences / seminars / workshops / symposiums / summits) were organized to discuss the potential of liposomes as novel drugdeliverysystems.
You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and DrugDeliverySystems Market. Oligonucleotide Synthesis, Modification and Purification Services Market. Our Social Media Platform.
They offer several advantages over traditional drugdeliverysystems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.
You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and DrugDeliverySystems Market. Next Generation Complement Therapeutics Market. Our Social Media Platform. Web: [link].
Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. These include broad-spectrum sunscreens, protective clothing and innovative skincare products developed using antioxidants and other protective agents. How is Medicus Pharma innovating in this space?
Therapies such as dexamethasone drugdeliverysystem and vascular endothelial growth factor inhibitors have already pierced deeper into the market. The company has plans to initiate new trials for the product however not until the second half of 2021.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content